These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage. Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW; Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908 [TBL] [Abstract][Full Text] [Related]
5. Initial Experience With High-Risk Patients Excluded From Clinical Trials: Safety of Short-Term Anticoagulation After Left Atrial Appendage Closure Device. Barakat AF; Hussein AA; Saliba WI; Bassiouny M; Tarakji K; Kanj M; Jaber W; Rodriguez LL; Grimm R; Hussain MS; Russman A; Uchino K; Wisco D; Rasmussen P; Bain M; Vargo J; Zuccaro G; Gottesman D; Lindsay BD; Wazni OM Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27225288 [TBL] [Abstract][Full Text] [Related]
6. Left Atrial Appendage Closure for Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation: the LAA-CAA Cohort. Schrag M; Mac Grory B; Nackenoff A; Eaton J; Mistry E; Kirshner H; Yaghi S; Ellis CR Transl Stroke Res; 2021 Apr; 12(2):259-265. PubMed ID: 32770310 [TBL] [Abstract][Full Text] [Related]
7. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure. Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322 [TBL] [Abstract][Full Text] [Related]
9. Left atrial appendage closure device implantation in patients at very high risk for stroke. Hutt E; Wazni OM; Kaur S; Saliba WI; Tarakji KG; Kapadia S; Aguilera J; Barakat AF; Abdallah M; Jaber W; Rasmussen P; Hussain S; Uchino K; Wisco D; Lindsay BD; Kanj M; Hussein AA Heart Rhythm; 2020 Jan; 17(1):27-32. PubMed ID: 31302250 [TBL] [Abstract][Full Text] [Related]
10. Left Atrial Appendage Closure in Patients With Intracranial Hemorrhage and Nonvalvular Atrial Fibrillation. Ajmal M; Naik H; Kocheril A J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104685. PubMed ID: 32057654 [TBL] [Abstract][Full Text] [Related]
11. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device. Kaneko H; Neuss M; Weissenborn J; Butter C Heart Vessels; 2017 Sep; 32(9):1137-1143. PubMed ID: 28477098 [TBL] [Abstract][Full Text] [Related]
12. Left Atrial Appendage Closure for Atrial Fibrillation Is Safe and Effective After Intracranial or Intraocular Hemorrhage. Fahmy P; Spencer R; Tsang M; Gooderham P; Saw J Can J Cardiol; 2016 Mar; 32(3):349-54. PubMed ID: 26831513 [TBL] [Abstract][Full Text] [Related]
13. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis. Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200 [TBL] [Abstract][Full Text] [Related]
14. Postapproval Community Hospital Experience in the United States with Left Atrial Appendage Closure Device (Watchman). Khalighi K; Sharma M; Masih R; Levin V J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2538-2542. PubMed ID: 29857929 [TBL] [Abstract][Full Text] [Related]
15. Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study. Casu G; D'Angelo G; Ugo F; Ronco F; Simonetto F; Barbierato M; Magni V; Boccuzzi G; Margonato A; Moroni F; Delitala A; Lorenzoni G; Beneduce A; Rametta F; Mazzone P; Della Bella P; Montorfano M; Merella P Int J Cardiol; 2021 Apr; 328():75-80. PubMed ID: 33245957 [TBL] [Abstract][Full Text] [Related]
16. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY; J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585 [TBL] [Abstract][Full Text] [Related]
17. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients. Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668 [TBL] [Abstract][Full Text] [Related]
18. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage. Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500 [TBL] [Abstract][Full Text] [Related]
19. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure. Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883 [TBL] [Abstract][Full Text] [Related]
20. Percutaneous Left Atrial Appendage Closure With the Watchman Device: Long-Term Results Up to 5 Years. Wiebe J; Franke J; Lehn K; Hofmann I; Vaskelyte L; Bertog S; Sievert H JACC Cardiovasc Interv; 2015 Dec; 8(15):1915-1921. PubMed ID: 26738659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]